Ricart, Alejandro D.
The University of Texas at San Antonio Health Science Center
3 papers on CoChat
Most cited papers
- Verified
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
Raez, L. E., Papadopoulos, K., Ricart, A. D., Chiorean, E. G., DiPaola, R. S., Stein, M. N., Rocha Lima, C. M., Schlesselman, J. J., Tolba, K., Langmuir, V. K., et al. (2013) · Cancer Chemotherapy and Pharmacology
Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer
Cited by 543
- Verified
A Phase II Study of PD-0325901, an Oral MEK Inhibitor, in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer
Haura, E. B., Ricart, A. D., Larson, T. G., Stella, P. J., Bazhenova, L., Miller, V. A., Cohen, R. B., Eisenberg, P. D., Selaru, P., Wilner, K. D., et al. (2010) · Clinical Cancer Research
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 237
- Verified
Phase I Study of E7820, an Oral Inhibitor of Integrin α-2 Expression with Antiangiogenic Properties, in Patients with Advanced Malignancies
Mita, M., Kelly, K. R., Mita, A., Ricart, A. D., Romero, O., Tolcher, A., Hook, L., Okereke, C., Krivelevich, I., Rossignol, D. P., et al. (2011) · Clinical Cancer Research
Angiogenesis and VEGF in CancerCell Adhesion Molecules Research
Cited by 71
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free